株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

化学療法薬の世界市場の分析:機会と予測

Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)

発行 Azoth Analytics 商品コード 817529
出版日 ページ情報 英文 200 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.65円で換算しております。
Back to Top
化学療法薬の世界市場の分析:機会と予測 Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)
出版日: 2019年03月31日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界の化学療法薬市場について調査分析し、統計と情報 (市場規模・シェア・成長要因) のほか、新興動向、主要促進要因、課題と機会、主要企業について、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 戦略的提言

第4章 化学療法薬市場の見通し

第5章 世界の化学療法薬市場:成長率と予測

  • 金額別 (実績)
  • 金額別 (予測)

第6章 世界の化学療法薬市場:セグメント別分析

  • 薬剤タイプ別
  • 代謝拮抗剤
  • 植物性アルカロイド
  • 抗がん剤
  • その他
  • 投与経路別
  • 静脈内
  • 経口
  • その他

第7章 世界の化学療法薬市場:地域別分析

  • 地域別:内訳
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第8章 世界の化学療法薬市場:市場力学

  • 市場促進要因
  • 市場抑制要因

第9章 世界の化学療法薬市場動向

第10章 ファイブフォース分析

第11章 SWOT分析

第12章 政策・規制情勢

第13章 企業プロファイル

  • Pfizer
  • Eli Lilly & Company
  • CELGENE Corporation
  • Bristol-Myers Squibb
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis
  • Sanofi
  • Teva Pharmaceuticals Industries Limited
図表

List of Figures

  • Figure 1: Common Treatment Modalities for Cancer
  • Figure 2: Cancer Treatment Flowchart
  • Figure 3: Chemotherapy Drugs Market Segmentation Flowchart
  • Figure 4: Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
  • Figure 5: Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 6: Key factors driving of change in the global oncology market
  • Figure 7: Projected global population (In Billions)
  • Figure 8: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
  • Figure 9: Projected global population aged 60 years & above (In Billions)
  • Figure 10: Global Health Expenditure Per Capita, By Select Countries, 2016 (In USD)
  • Figure 11: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
  • Figure 12: Global Burden of Cancer
  • Figure 13: Prevalence and Epidemiology of Cancer Worldwide
  • Figure 14: 5 Year Survival Rate, Breast and Colorectal Cancer
  • Figure 15: Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted
  • Figure 16: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
  • Figure 17: Global Prevalence of Prostate Cancer (2013-2017, Thousands)
  • Figure 18: Oncologists per 1 Million of Population, By Select Country, 2018
  • Figure 19: Availability of New Cancer Drugs Launched in 2012-2016, By Select Country (As of 2017)
  • Figure 20: Global Antimetabolite Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 21: Global Antimetabolite Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 22: Global Plant Alkaloid Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 23: Global Plant Alkaloid Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 24: Global Alkylating Agent Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 25: Global Alkylating Agent Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 26: Global Anti-tumor Antibiotic Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 27: Global Anti-tumor Antibiotic Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 28: Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 29: Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 30: Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
  • Figure 31: Global Chemotherapy Drugs Market Size,By Route of Administration, 2023 (%)
  • Figure 32: Global Intravenous Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 33: Global Intravenous Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 34: Global Oral Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 35: Global Oral Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 36: Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
  • Figure 37: Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 38: Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
  • Figure 39: Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
  • Figure 40: North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
  • Figure 41: North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 42: North America GDP, 2012-2017 (USD Trillion)
  • Figure 43: North America GDP per capita, current prices, 2013-2023F (In USD)
  • Figure 44: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
  • Figure 45: North America, Cancer Incidence (In Millions)
  • Figure 46: North America, Cancer Incidence, By Route of Administration, 2019E (In %)
  • Figure 47: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
  • Figure 48: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
  • Figure 49: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
  • Figure 50: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
  • Figure 51: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
  • Figure 52: U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 53: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
  • Figure 54: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
  • Figure 55: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
  • Figure 56: Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
  • Figure 57: Estimated New Cases of Cancer in the United States, By State, 2018
  • Figure 58: Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
  • Figure 59: Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
  • Figure 60: Factors Influencing Patient Out-of-Pocket Costs for Cancer Medicines
  • Figure 61: United States, Top Players in the chemotherapy drugs market, By Company Share, 2017 (%)
  • Figure 62: Canada Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 63: Cancer Burden in Canada, 2017
  • Figure 64: Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)
  • Figure 65: Cancer Fact Sheet of Canada, 2017
  • Figure 66: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
  • Figure 67: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
  • Figure 68: North America Chemotherapy Drugs Market, Country Share, 2013-2017 (% of Total)
  • Figure 69: North America Chemotherapy Drugs Market, Country Share, 2018F-2023F (% of Total)
  • Figure 70: Europe Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
  • Figure 71: Europe Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 72: Europe, Cancer Incidence, 2019E-2035F (In Millions)
  • Figure 73: Europe, Cancer Incidence, By Type, 2019E
  • Figure 74: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
  • Figure 75: Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)
  • Figure 76: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
  • Figure 77: Breakdown of Total Health Expenditure in Europe, 2018 (%)
  • Figure 78: Major Players in Chemotherapy Drugs Market in Europe
  • Figure 79: Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
  • Figure 80: Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
  • Figure 81: Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
  • Figure 82: Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
  • Figure 83: Germany Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 84: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 85: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
  • Figure 86: U.K Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 87: Cancer Statistics in the United Kingdom
  • Figure 88: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 89: Europe Chemotherapy Drugs Market, Country Share, Historic, 2013-2017(% of Total)
  • Figure 90: Europe Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
  • Figure 91: APAC Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
  • Figure 92: APAC Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
  • Figure 93: Estimated number of deaths from prostate cancer in 2012 and 2030
  • Figure 94: World health expenditure as % of GDP
  • Figure 95: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
  • Figure 96: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
  • Figure 97: APAC, GDP, By Select Country, 2017 (In USD Trillion)
  • Figure 98: APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
  • Figure 99: APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
  • Figure 100: APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
  • Figure 101: APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
  • Figure 102: India Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 103: Key factors affecting the Indian Healthcare Industry
  • Figure 104: India, Total Population, 2013-2023F (In Billion)
  • Figure 105: India, Share of Urban Population, 2012-2017 (In %)
  • Figure 106: India, GDP Growth Per Year, 2015-2019 (In %)
  • Figure 107: India, Total deaths due to cancer, 2018
  • Figure 108: Top 5 forms of cancer in men and women in India
  • Figure 109: China Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 110: China, GDP Growth Per Year, 2015-2019 (In %)
  • Figure 111: China, Share of Urban Population, 2012-2017 (In %)
  • Figure 112: China, Total Population, 2013-2021F (In Billion)
  • Figure 113: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
  • Figure 114: Number of new cases, Males (all ages), 2018 (In %)
  • Figure 115: Number of new cases, Females (all ages), 2018 (In %)
  • Figure 116: China, Cancer Mortality Rate, By Cancer Site, 2018
  • Figure 117: APAC Chemotherapy Drugs Market, Country Share, Historic, 2013-2017 (% of Total)
  • Figure 118: APAC Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
  • Figure 119: ROW Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
  • Figure 120: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
  • Figure 121: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
  • Figure 122: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
  • Figure 123: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
  • Figure 124: ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
  • Figure 125: ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
  • Figure 126: ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
  • Figure 127: ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
  • Figure 128: Drug Discovery and Development, Approximate Timeline
  • Figure 129: Pfizer, Revenue, 2013-2017 (In USD Billion)
  • Figure 130: Pfizer, Revenue, By Business Segment, 2017 (In %)
  • Figure 131: Pfizer, Revenue, By National Market, 2015-2017 (In %)
  • Figure 132: Pfizer, Oncology Revenue, 2015-2017 (In USD Million)
  • Figure 133: Eli Lilly & Company, Revenue, 2013-2017 (In USD Billion)
  • Figure 134: Eli Lilly & Company, Revenue, By Business Segment, 2017 (In %)
  • Figure 135: Eli Lilly & Company, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 136: CELGENE Corporation, Revenue, 2013-2017 (In USD Million)
  • Figure 137: CELGENE Corporation, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 138: Bristol-Myers Squibb, Revenue, 2013-2017 (In USD Million)
  • Figure 139: Bristol-Myers Squibb, Revenue, By Business Segment, 2017 (In %)
  • Figure 140: Bristol-Myers Squibb, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 141: Merck & Co., Inc., Revenue, 2013-2017 (In USD Million)
  • Figure 142: Merck & Co., Inc., Net Sales, By Geographic Region, 2017 (In %)
  • Figure 143: GlaxoSmithKline plc, Revenue, 2013-2017 (In USD Million)
  • Figure 144: GlaxoSmithKline plc, Revenue, By Business Segment, 2017 (In %)
  • Figure 145: GlaxoSmithKline plc, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 146: Novartis, Revenue, 2014-2018 (In USD Million)
  • Figure 147: Novartis, Net Sales, By Business Segment, 2017 (In %)
  • Figure 148: Sanofi, Revenue, 2013-2017 (In USD Million)
  • Figure 149: Sanofi , Revenue, By Business Segment, 2017 (In %)
  • Figure 150: Sanofi, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 151: Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, 2013-2017 (In USD Million)
  • Figure 152: Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, By Business Segment, 2017 (In %)
  • Figure 153: Teva Pharmaceutical INDUSTRIES LIMITED, Net Sales, By Geographic Region, 2017 (In %)

List of Tables

  • Table A: Approach and Limitations of Common Treatment Modalities for Cancer
  • Table B: Recent Company Acquisitions and Mergers in Chemotherapy Drugs Market
  • Table C: Germany, Healthcare Related Statistics, 2017
  • Table D: Estimated number of people living with cancer, 2020F and 2030F
  • Table E: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
  • Table F: India, Cancer Statistics
目次

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Chemotherapy Drugs Market. The report analyzes the Chemotherapy Drugs Market, By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others), By Route of Administration (Oral, Intravenous, Others). The chemotherapy drugs market has been analyzed By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, United Kingdom, Germany, China and India) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)", global market is projected to display a robust growth represented by a CAGR of 11.91% during 2018 - 2023.

On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments.

The report titled "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)" has covered and analyzed the potential of global chemotherapy drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global chemotherapy drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

  • Global Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Regional Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Other Report Highlights:

  • Market Dynamics - Drivers and Restraints
  • Market Trends
  • SWOT Analysis
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited.

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Chemotherapy Drugs Market Outlook

5. Global Chemotherapy Drugs Market: Growth and Forecast

  • 5.1 By Value (2013-2017)
  • 5.2 By Value (2018-2023)

6. Global Chemotherapy Drugs Market: Segment Analysis

  • 6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.4 Other Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)
    • 6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
    • 6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)
  • 6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023)
  • 6.7 Other Chemotherapy Drugs Market, By Value (2013-2023)

7. Global Chemotherapy Drugs Market: Regional Analysis

  • 7.1 Global Chemotherapy Drugs Market Size, By Region : Breakdown (%)
    • 7.1.1 Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
    • 7.1.2 Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
  • 7.2 North America Chemotherapy Drugs Market: Growth and Forecast
    • 7.2.1 By Value (2013-2017)
    • 7.2.2 By Value (2018-2023)
    • 7.2.3 By Type of Drug, By Value (2013-2017)
    • 7.2.4 By Type of Drug, By Value (2018-2023)
    • 7.2.5 By Route of Administration, By Value (2013-2017)
    • 7.2.6 By Route of Administration, By Value (2018-2023)
  • 7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada)
    • 7.3.1 U.S Chemotherapy Drugs Market, By Value (2013-2023)
    • 7.3.2 Canada Chemotherapy Drugs Market, By Value (2013-2023)
  • 7.4 Europe Chemotherapy Drugs Market: Growth and Forecast
    • 7.4.1 By Value (2013-2017)
    • 7.4.2 By Value (2018-2023)
    • 7.4.3 By Type of Drug, By Value (2013-2017)
    • 7.4.4 By Type of Drug, By Value (2018-2023)
    • 7.4.5 By Route of Administration, By Value (2013-2017)
    • 7.4.6 By Route of Administration, By Value (2018-2023)
  • 7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)
    • 7.5.1 Germany Chemotherapy Drugs Market, By Value (2013-2023)
    • 7.5.2 U.K Chemotherapy Drugs Market, By Value (2013-2023)
  • 7.6 APAC Chemotherapy Drugs Market: Growth and Forecast
    • 7.6.1 By Value (2013-2017)
    • 7.6.2 By Value (2018-2023)
    • 7.6.3 By Type of Drug, By Value (2013-2017)
    • 7.6.4 By Type of Drug, By Value (2018-2023)
    • 7.6.5 By Route of Administration, By Value (2013-2017)
    • 7.6.6 By Route of Administration, By Value (2018-2023)
  • 7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China)
    • 7.7.1 India Chemotherapy Drugs Market, By Value (2013-2023)
    • 7.7.2 China Chemotherapy Drugs Market, By Value (2013-2023)
  • 7.8 ROW Chemotherapy Drugs Market: Growth and Forecast
    • 7.8.1 By Value (2013-2017)
    • 7.8.2 By Value (2018-2023)
    • 7.8.3 By Type of Drug, By Value (2013-2017)
    • 7.8.4 By Type of Drug, By Value (2018-2023)
    • 7.8.5 By Route of Administration, By Value (2013-2017)
    • 7.8.6 By Route of Administration, By Value (2018-2023)

8. Global Chemotherapy Drugs Market Dynamics

  • 8.1 Global Chemotherapy Drugs Market Drivers
  • 8.2 Global Chemotherapy Drugs Market Restraints

9. Global Chemotherapy Drugs Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

14. Company Profiles

  • 14.1 Pfizer
  • 14.2 Eli Lilly & Company
  • 14.3 CELGENE Corporation
  • 14.4 Bristol-Myers Squibb
  • 14.5 Merck & Co., Inc.
  • 14.6 GlaxoSmithKline plc
  • 14.7 Novartis
  • 14.8 Sanofi
  • 14.9 Teva Pharmaceuticals Industries Limited
Back to Top